Archives: Agenda

END OF DAY 1 AND NETWORKING DRINKS

Best 3 LinkedIn posts from day 1 with hashtag #OCT and @Outsourcing in Clinical Trials Event Series tagged will win a prize in day 2 morning’s prize draw during chair’s opening remarks. Deadline end of drinks reception day 1. You must be present to win!

From Trial to Real World: Strategic Clinical Development Beyond Traditional CRO Models – Rethinking Partnership Models to Move From Trial To Real-World Impact

  • Closing the Gap Between Trial and Impact: Translating clinical evidence into real-world outcomes: ensuring data supports access, reimbursement decisions, and ultimately, better lives for patients.
  • Embedding Real-World Evidence from Day One: How strategic partnerships enable early RWE planning
  • Redefining Partnership: Moving from vendor relationships to true collaboration
  • Why Rare Diseases Are Different: The case for deeper Sponsor–CRO integration: navigating small patient populations, accelerating site activation and enrollment

CLOSING PANEL DISCUSSION The Feasibility Crisis: Are Sponsors Pushing Sites Beyond Capacity?

  • Why recruitment forecasts and feasibility assessments across the DACH region continue to miss targets despite strong research infrastructure and healthcare systems
  • How increasing study competition, protocol complexity, and limited patient availability are placing growing pressure on sites
  • The operational challenges impacting recruitment and patient access across the region
  • How sponsors, CROs, and sites can work together to create more realistic feasibility strategies and more sustainable approaches to patient recruitment and site engagement

2 seats available for biotech/ pharma

1 seat available for event sponsor

PANEL DISCUSSION Future-Proofing Clinical Trials with AI: Will Today’s AI Strategies Survive Tomorrow’s Clinical Trial Landscape?

  • Exploring how AI can support end-to-end clinical trial delivery, from protocol authoring and risk assessment through to data analysis and reporting
  • Examining how historical trial outcomes, regulatory feedback, and operational data can be leveraged to improve planning, country selection, site strategy, and database design
  • Understanding how AI-driven connectivity across departments can break down silos and create a more integrated approach to trial execution
  • Discussing how organisations can operationalise AI strategically to future-proof clinical development processes rather than applying disconnected point solutions

Moderator: Andreas Panteli, Director, Clinical Trial Recruitment/ Operations, Novartis

1 seat available for event sponsor

END OF DAY 1 AND NETWORKING DRINKS

Best 3 LinkedIn posts from day 1 with hashtag #CTO and @Clinical Trials in Oncology Event Series tagged will win a prize in day 2 morning’s prize draw during chair’s opening remarks. Deadline end of drinks reception day 1. You must be present to win!

EMERGING BIOTECH SPOTLIGHT Doing More with Less: Optimizing Clinical Development Strategies in Resource-Constrained Environments

  • Leveraging adaptive trial designs to enhance evidence generation and patient outcomes for products using new routes of administration
  • Exploring multiple funding strategies to sustain innovation in challenging market conditions
  • CEO case study: Lessons learned from advancing innovative oncology therapies despite resource constraints
  • Determining when sufficient clinical evidence exists to support accelerated approval and regulatory success